Provided by Tiger Trade Technology Pte. Ltd.

Lineage

37.75
+0.36000.96%
Post-market: 37.750.00000.00%19:30 EDT
Volume:1.05M
Turnover:39.68M
Market Cap:8.57B
PE:-52.43
High:37.95
Open:37.40
Low:37.09
Close:37.39
52wk High:45.75
52wk Low:31.33
Shares:227.08M
Float Shares:57.19M
Volume Ratio:1.19
T/O Rate:1.84%
Dividend:2.12
Dividend Rate:5.62%
EPS(TTM):-0.7200
EPS(LYR):-0.4300
ROE:-2.04%
ROA:0.75%
PB:1.09
PE(LYR):-87.79

Loading ...

The Bull Case For Lineage (LINE) Could Change Following Portfolio Review And Deleveraging Plans - Learn Why

Simply Wall St.
·
Jun 05

A Look At Lineage (LINE) Valuation As Recovery Signals And REITweek Update Draw Investor Attention

Simply Wall St.
·
Jun 03

Lineage Is Maintained at Equal-Weight by Morgan Stanley

Dow Jones
·
Jun 02

Lineage Shows Early Recovery Signs as Demand Stabilizes, Morgan Stanley Says

MT Newswires Live
·
Jun 02

Lineage Inc : Morgan Stanley Raises Target Price to $47 From $39

THOMSON REUTERS
·
Jun 02

Morgan Stanley Raises Price Target on Lineage to $47 From $39, Keeps Equalweight Rating

MT Newswires Live
·
Jun 02

Lineage releases investor presentation on temperature-controlled warehouse REIT business and cold-chain logistics strategy

Reuters
·
Jun 02

Lineage Is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
Jun 01

“K” LINE Launches Up to ¥130 Billion Share Buyback on Tokyo Stock Exchange

TIPRANKS
·
Jun 01

What Lineage (LINE)'s Q1 Move From Profit to Loss Means For Shareholders

Simply Wall St.
·
May 19

Lineage Is Maintained at Underweight by Barclays

Dow Jones
·
May 15

Analysts Offer Insights on Real Estate Companies: First Industrial Realty (FR) and Lineage, Inc. (LINE)

TIPRANKS
·
May 15

Lineage price target raised to $35 from $34 at Barclays

TIPRANKS
·
May 15

RBC Capital Keeps Their Buy Rating on Lineage, Inc. (LINE)

TIPRANKS
·
May 15

Lineage, Inc. (LINE) Receives a Buy from Goldman Sachs

TIPRANKS
·
May 14

Lineage Cell Therapeutics Highlights R&D Momentum Amid Losses

TIPRANKS
·
May 14

Lineage Cell Therapeutics reports Q1 EPS (3c), consensus (2c)

TIPRANKS
·
May 13

Lineage Cell sees cash, equivalents funding operations into 2Q28

TIPRANKS
·
May 13

Lineage Cell Therapeutics Q1 EPS $(0.03) Misses $(0.02) Estimate, Sales $1.725M Miss $3.602M Estimate

Benzinga Earnings
·
May 13

Press Release: Lineage Cell Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
May 13